Overview

Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
A comparison of fibrin sealant 2 versus Surgicel® as an addition to standard surgical practice in stopping mild to moderate soft tissue bleeding during retroperitoneal or intra-abdominal surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Ethicon, Inc.
Collaborator:
OMRIX Biopharmaceuticals
Treatments:
Fibrin Tissue Adhesive